Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.
Press releases published on May 19, 2025
Appili Therapeutics Provides Update on Arrangement with Aditxt, Inc.
GlobeNewswire
·
May 19, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, May 19, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical …
Global Ship Lease Reports Results for the First Quarter of 2025
GlobeNewswire
·
May 19, 2025
Forward contract cover locked in for 93% of 2025 days and 75% of 2026 days Annualized dividend increased to $2.10 per Class A Common Share ATHENS, Greece, May 19, 2025 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE: GSL) (the “Company”, “Global Ship …
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
GlobeNewswire
·
May 19, 2025
GARCHING / MUNICH, Germany and SYDNEY, May 19, 2025 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX “Radiopharm”), a developer of a world-class …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
May 19, 2025
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from May 12, 2025 to May 16, 2025 AMSTERDAM – May 19, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global …
SISCAPA and Biognosys Announce Strategic Collaboration to Deliver End-to-End High-Sensitivity Targeted Protein Quantification Solutions
GlobeNewswire
·
May 19, 2025
WASHINGTON and ZURICH, May 19, 2025 (GLOBE NEWSWIRE) -- SISCAPA Assay Technologies, a global leader in high-sensitivity protein quantitation, and Biognosys, a pioneer in next-generation proteomics, today announced an exclusive strategic collaboration to …
Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress
GlobeNewswire
·
May 19, 2025
Results from MUSIC-HFpEF Phase 1/2a clinical trial show favorable safety profile and early clinical benefits with SRD-002 gene therapy BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on …
Eascra Biotech Awarded $100,000 MassVentures START Grant
GlobeNewswire
·
May 19, 2025
BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech, a nanomedicine startup, has been awarded a $100,000 Stage I SBIR Targeted Technologies (START) grant funded by the Commonwealth and managed by MassVentures. The funding is to support their work on …
Critical Metals Corp Releases Further Excellent Deep High-Grade Drilling Results on Tanbreez (TREO 0.48% & HREO 27%)
GlobeNewswire
·
May 19, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, is pleased to publish for the first time the assay results of historical deep diamond …
180 Degree Capital Corp. Issues Q1 2025 Shareholder Letter
GlobeNewswire
·
May 19, 2025
MONTCLAIR, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) today issued the following Q1 2025 Shareholder Letter: Fellow Shareholders, As discussed in our press release issued on April 14, 2025, we ended the first quarter of …
Patriot Bank Expands Its Board and Senior Leadership Team
GlobeNewswire
·
May 19, 2025
Richard Smith, Jeff Seabold and Thedora Nickel elected Directors. Paul Simmons appointed EVP, Chief Credit Officer Nicole L. Wells appointed SVP, Head of Operations Rebecca Mais appointed SVP, High Net Worth and Specialty Deposits Raquel Gillett appointed …
RedCloud Reports Full Year 2024 Results
GlobeNewswire
·
May 19, 2025
LONDON, May 19, 2025 (GLOBE NEWSWIRE) -- Trading platform company RedCloud Holdings plc (RCT) (“RedCloud” or “The Company”) today reported its financial and business results for the full year 2024. Full Year 2024 Financial Highlights include: • FY 2024 …
Vaidio Showcases 9th Generation Vision AI Platform at COMPUTEX 2025
GlobeNewswire
·
May 19, 2025
TAIPEI, Taiwan, May 19, 2025 (GLOBE NEWSWIRE) -- Vision AI leader Vaidio® announced today it will showcase the 9th generation of its widely-adopted AI Vision Platform at COMPUTEX 2025, taking place at the Taipei Nangang Exhibition Center from May 20 to May …
Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders
GlobeNewswire
·
May 19, 2025
SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced that …
TopBuild Extends and Upsizes Senior Secured Credit Facilities
GlobeNewswire
·
May 19, 2025
DAYTONA BEACH, Fla., May 19, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE: BLD), a leading installer and specialty distributor of insulation and building material products to the construction industry in the United States and Canada, today announced the …
AMD Announces Agreement to Divest ZT Systems Data Center Infrastructure Manufacturing Business to Sanmina
GlobeNewswire
·
May 19, 2025
$3 billion in cash and stock, inclusive of a contingent payment of up to $450 million AMD retains ZT Systems’ rack-scale AI solutions design and customer enablement expertise to accelerate quality and time-to-deployment for cloud customers Divestiture and …
Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000
GlobeNewswire
·
May 19, 2025
TORONTO, May 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that after receiving approval from the Board of Directors, the Company has purchased an …
Gradient Denervation Technologies annonce que son système de dénervation de l’artère pulmonaire a obtenu la désignation de dispositif innovant par la FDA
GlobeNewswire
·
May 19, 2025
PARIS, 19 mai 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies a annoncé aujourd’hui que son système de dénervation pulmonaire a reçu la désignation de dispositif innovant de la part de la Food and Drug Administration (FDA), l’Agence américaine …
Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System
GlobeNewswire
·
May 19, 2025
PARIS, May 19, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This program creates an …
Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness
GlobeNewswire
·
May 19, 2025
Purchase is subject to bankruptcy court and regulatory approvals Regeneron will prioritize the privacy, security and ethical use of 23andMe’s customer data; stands ready to work with independent, court-appointed Customer Privacy Ombudsman Planned purchase …
Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale
GlobeNewswire
·
May 19, 2025
Regeneron Commits to Comply with Company’s Privacy Policy and All Applicable Law; No Changes to 23andMe’s Privacy Policy or Consumer Genome Services Transaction Subject to Court Approval SAN FRANCISCO, May 19, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. …